CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating Activities:
Net income/(loss)	$ (9,996,824)	$ (6,610,034)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	50,224	34,503
Share-based compensation	1,965,311
Operating lease asset amortization	394,638	340,114
Accretion of debt discount	1,542,085	2,086,301
Loss on equity method investment	170	2
Inventory reserve expense	83,357
Changes in operating assets and liabilities:
Accounts receivable	(13,147)	(786,824)
Inventories	(146,362)	(85,934)
Prepaid expenses and other current assets	17,330	(559,774)
Accounts payable	557,146	185,596
Related party payable	(51,971)	7,127
Operating lease liabilities	(384,708)	(322,729)
Accrued interest	113,909	30,383
Accrued expenses	(708,984)	305,585
Net cash used in operating activities	(6,577,826)	(5,375,684)
Investing Activities:
Contributions to equity method investment		(83,559)
Payments on purchase of assets	(3,841,373)	(66,053)
Patent activity costs	(8,169)	(7,192)
Net cash used in investing activities	(3,849,542)	(156,804)
Financing Activities:
Proceeds from issuance of Series 1B Preferred Stock	880,000
Payment of convertible notes	(1,025,423)
Net cash used in financing activities	(145,423)
Effect of foreign exchange rate on cash	(4,606)
Net change in cash and cash equivalents	(10,577,397)	(5,532,488)
Cash and cash equivalents at beginning of period	11,483,018	5,961,760
Cash and cash equivalents at end of period	905,621	429,272
Non-Cash Transactions:
Right-of-use assets acquired through operating lease liabilities		21,045
Purchase of equipment not yet paid at end of period		213,922
Non-cash conversions of convertible notes to equity	3,364,467	9,200,000
Series 1A preferred stock conversion		$ 740
Down round deemed dividend	11,653,986
Supplemental disclosure of cash flow information:
Interest	$ 173,600